Publications
Publications
Show Results For
- All HBS Web
(14,842)
- Faculty Publications (5,027)
- May 2024
- Article
Financial Innovation in the 21st Century: Evidence from U.S. Patents
By: Josh Lerner, Amit Seru, Nick Short and Yuan Sun
We develop a unique dataset of 24 thousand U.S. finance patents granted over the last two decades to explore the evolution and production of financial innovation. We use machine learning to identify the financial patents and extensively audit the results to ensure... View Details
- (Revised May 2024)
- Teaching Note
Lyric Dinner Theater (A) and (B)
By: Richard G. Hamermesh, Jim Sharpe and Noah Fisher
This teaching note is associated with HBS cases 813-043 and 813-044. View Details
- May–June 2024
- Article
What Makes a Successful Celebrity Brand?
Celebrities have shifted from endorsing established brands to being influencers for established brands to drawing on their influence to create brands themselves. The authors examine what it takes to make celebrity brands work. View Details
Keywords: Celebrities; Celebrity Endorsement; Celebrity Management; Celebrity; Direct To Consumer Marketing; DTC; Influencer Marketing; Influencers; Influencer Advertising; Influencer; Brands and Branding; Product Marketing; Power and Influence; Advertising; Social Media; Consumer Products Industry; United States
- April 2024 (Revised December 2024)
- Case
Anthropic: Building Safe AI
By: Shikhar Ghosh and Shweta Bagai
In late 2024, Anthropic, a leading AI safety and research company, achieved a significant breakthrough with computer use capabilities that allowed AI to interact with computers like humans. Co-founded by former OpenAI employees and known for its generative AI... View Details
- 2024
- Working Paper
Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency
By: Mosab Hammoudeh, Joshua Lev Krieger and Jiajie Xu
This paper investigates whether moving R&D from incumbents to startups can increase innovation. Using comprehensive drug development data, we examine the outcomes of drug projects licensed from large firms to startups. We find that these projects licensed to startups... View Details
- April 2024
- Case
Managing AI Risks in Consumer Banking
By: Suraj Srinivasan, Satish Tadikonda, Paul Dongha, Manoj Saxena and Radhika Kak
In early 2024, Ruth Jones, head of digital banking at Signa Bank, a (fictitious) European consumer bank, was thinking about how to best incorporate GenAI capabilities to improve efficiencies and create new ways to improve the customer experience. Where were the biggest... View Details
- 2024
- Working Paper
Human-Computer Interactions in Demand Forecasting and Labor Scheduling Decisions
By: Caleb Kwon, Ananth Raman and Jorge Tamayo
We investigate whether corporate officers should grant managers discretion to override AI-driven demand forecasts and labor scheduling tools. Analyzing five years of administrative data from a large grocery retailer using such an AI tool, encompassing over 500 stores,... View Details
- April 2024
- Case
Qualcomm, Inc. in 2024
By: David B. Yoffie and Sarah von Bargen
Qualcomm was facing a new era in 2024. After a judge’s adverse anti-trust decision almost destroyed Qualcomm’s business model, the company was victorious on appeal. The new CEO was optimistic about new growth opportunities in technologies such as 5G, AI, and augmented... View Details
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Pharmaceutical Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
- April 2024 (Revised February 2025)
- Teaching Note
eBee: Affordable Mobility for Africa
By: Ramon Casadesus-Masanell, Gamze Yucaoglu and Jordan Mitchell
Teaching Note for HBS Case No. 724-360.The case opens in March 2023, as Sten van der Ham and Jaap Maljers, CEO and co-founder of eBee, an electric bike (e-bike) company in Africa, are contemplating the different avenues for growth and path to profitability for the... View Details
- April 2024 (Revised November 2024)
- Case
Moderna: Pioneering a People Platform to Accelerate Science Innovation
By: Tatiana Sandino, Emil Dy and Samuel Grad
Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for the body to create antibodies. When Stéphane Bancel (HBS 2000) took over in 2011, he bet on the potential of this... View Details
Keywords: Disruptive Innovation; Talent and Talent Management; Selection and Staffing; AI and Machine Learning; Digital Strategy; Innovation and Management; Leadership Development; Management Practices and Processes; Management Systems; Organizational Culture; Performance Evaluation; Alignment; Employee Relationship Management; Science-Based Business; Expansion; Pharmaceutical Industry; Biotechnology Industry; United States
- April 2024
- Supplement
RHI Magnesita (B): Brick by Brick—Diversification?
By: Ramon Casadesus-Masanell, David M Wagner, Oliver Gassmann and Jordan Mitchell
In Part A, as of April 2017, Austria’s RHI, a backward integrated refractory company is still within the midst of merging with the next biggest competitor, Brazil’s Magnesita, while weighing options for future growth. Should the company pursue organic growth options... View Details
- 2024
- Book
The Ritual Effect: From Habit to Ritual, Harness the Surprising Power of Everyday Actions
By: Michael Norton
Our lives are filled with repetitive tasks meant to keep us on track—what we come to know as habits. Over time, these routines (for example, brushing your teeth or putting on your right sock first) tend to be performed automatically. But when we’re more mindful about... View Details
- Second Quarter 2024
- Article
Venture Capital in a Time of Turmoil
By: Josh Lerner
One area of consensus among academic
economists and policymakers is the need
for greater innovation. This concern is
rooted in worries about the lagging rate
of productivity growth in many Western
nations. In the U.S., for instance, the productivity growth rate... View Details
- March 2024
- Case
Negotiating the Gift of Life (A)
By: Alex Chan
Describes a negotiation where lives are truly at stake, where key lessons on persuasion and the role that identity might play in a negotiation are on display through an effort by a frontline negotiator from OneLegacy, the US's largest organ procurement organization. As... View Details
Keywords: Economics; Negotiation; Communication; Diversity; Nonprofit Organizations; Emotions; Health Industry
- March 2024
- Supplement
Negotiating the Gift of Life (B)
By: Alex Chan
Describes a negotiation where lives are truly at stake, where key lessons on persuasion and the role that identity might play in a negotiation are on display through an effort by a frontline negotiator from OneLegacy, the US's largest organ procurement organization. As... View Details
- March 2024 (Revised July 2024)
- Case
WeightWatchers: Promoting Weight Health
In December 2023, the 60-year-old weight management industry stalwart WeightWatchers announced the launch of WeightWatchers Clinic, which incorporated GLP-1s , a new class of prescription weight-loss medications, into the company’s portfolio of products and mobile app... View Details
- March 2024 (Revised November 2024)
- Case
Kawasaki Heavy Industries Bets on Clean Hydrogen
By: Gunnar Trumbull, Nobuo Sato and Akiko Kanno
Kawasaki Heavy Industries (KHI), an engineering manufacturer headquartered in Japan, was aiming to scale up its hydrogen production and establish a global hydrogen supply chain. The initiative was in line with Japan's energy strategy, as the country seeks to transition... View Details
- March 2024
- Case
ixigo
By: Ranjay Gulati and Rachna Tahilyani
Ixigo is India’s second-largest online travel aggregator (OTA) and the market leader among private train OTAs. It has overcome numerous near-death crises to emerge as a customer-centric, profitable firm. It aspires to become the leading OTA in the next billion Internet... View Details
- March 2024
- Case
Lyft 2023: Roads to Growth and Differentiation
By: Ranjay Gulati and Jeffrey Huizinga
Set in San Francisco in winter 2023, this case explores the strategic challenges and initiatives at Lyft under the leadership of its new CEO, David Risher. Confronted with declining market share and financial pressures, Risher spent his first six months at the helm... View Details